搜索临床试验以:地拉罗司 DFX, DT
总计1136个结果
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology完全的
-
British Columbia Cancer AgencyGenomic Health®, Inc.未知
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)终止
-
Kyushu UniversityJapan Agency for Medical Research and Development; Ministry of Health, Labour and Welfare, Japan主动,不招人
-
Dimerix Bioscience Pty Ltd招聘中FSGS美国, 阿根廷, 澳大利亚, 丹麦, 法国, 香港, 新西兰, 西班牙, 台湾, 英国, 巴西
-
PTC TherapeuticsParexel; Dohmen Life Science Services批准上市
-
National Institute of Neurological Disorders and...招聘中
-
Kansas City Heart Rhythm Research Foundation招聘中
-
Medtronic Cardiovascular主动,不招人
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals完全的
-
Wolfson Medical CenterHadassah Medical Organization; Tel-Aviv Sourasky Medical Center; Sheba Medical Center; Soroka University...完全的
-
Washington University School of MedicineMillennium Pharmaceuticals, Inc.; Multiple Myeloma Research Consortium主动,不招人
-
Gruppo Italiano Malattie EMatologiche dell'Adulto完全的
-
Novartis Pharmaceuticals完全的Β-地中海贫血输血铁过载美国, 希腊, 阿根廷, 德国, 比利时, 意大利, 英国, 法国, 突尼斯, 加拿大, 火鸡, 巴西
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, Germany招聘中
-
Amsterdam UMC, location VUmcFoundation for the National Institutes of Health尚未招聘
-
Lundquist Institute for Biomedical Innovation at...Novartis; Gilead Sciences; Astellas Pharma Inc完全的
-
Shandong UniversityQingdao University; Liaocheng People's Hospital; Linyi People's Hospital未知
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching Hospitals NHS Trust; Cambridge University Hospitals NHS Foundation Trust 和其他合作者完全的
-
Fondazione Italiana Sindromi Mielodisplastiche-ETS终止
-
National Taiwan University HospitalUniversity of Michigan未知
-
TakedaTakeda Development Center Americas, Inc.完全的血管性水肿美国, 西班牙, 荷兰, 匈牙利, 意大利, 加拿大, 德国, 法国, 日本, 波兰
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Novartis Pharmaceuticals完全的骨髓增生异常综合征 | 范可尼综合症 | 贫血,再生障碍性 | Β-地中海贫血 | 贫血,Diamond-Blackfan美国
-
Novartis Pharmaceuticals撤销Focus on Transfusion Dependent Thalassemia Patients Who Are Inadequate Responders to Deferasirox > 35mg/kgQD
-
Novartis Pharmaceuticals终止
-
Novartis Pharmaceuticals完全的
-
Foundation for Innovative New Diagnostics, SwitzerlandUniversidad Peruana Cayetano Heredia; Burnet Institute; National Institute for Research in Tuberculosis... 和其他合作者完全的
-
Antonia NewNational Institute of Mental Health (NIMH); New York State Psychiatric Institute完全的
-
Dimerix Bioscience Pty LtdIqvia Pty Ltd完全的